吸烟损害慢性骨髓增殖性肿瘤患者的分子学缓解并降低总生存
该回顾性队列研究纳入498例连续诊断的慢性骨髓增殖性肿瘤(MPN)患者,其中270例有超过1次JAK2V617F等位基因频率检测。分析显示,从不吸烟者的分子学缓解率显著高于当前吸烟者,且总生存也显著更优;结论提示吸烟降低MPN患者的分子学缓解率和总生存,应鼓励戒烟。
要点
- 应鼓励MPN患者戒烟。
核心结论
- 吸烟降低MPN患者的分子学缓解率和总生存。
- 应鼓励MPN患者戒烟。
研究设计与样本
- 回顾性队列研究,分析498例连续诊断的MPN患者。
- 亚组分析270例有超过1次JAK2V617F等位基因频率检测的连续MPN患者。
- 采用Kaplan-Meier曲线、Cox回归分析和线性回归模型分析数据。
主要发现
- 采用不同部分分子学缓解截断值时观察到相似结果。
- 仅纳入干扰素-α2治疗患者的亚组分析显示相似结果。
- 在聚乙二醇干扰素-α2治疗患者中差异更明显,但未观察到干扰素-α2治疗的显著交互作用。
临床怎么用
- 临床应鼓励MPN患者戒烟,以改善分子学缓解和总生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The effects of smoking on the molecular response (MR) and overall survival (OS) in patients with chronic myeloproliferative neoplasms (MPNs) have not been investigated before. We analysed a historical cohort of 498 consecutive patients diagnosed with MPNs. Moreover, we analysed a subgroup of 270 consecutive patients with MPNs with > 1 measurement of the JAK2V617F variant allele frequency. The data were analysed using Kaplan-Meier plots and Cox regression analysis, along with linear regression models. In all patients, the rate of MR was significantly higher in never-smokers compared with current smokers in the univariate model (HR, 1·9; 95% CI, 1·1-3·3; P = 0·033) and the multivariate model (HR, 1·9; 95% CI, 1·1-3·5; P = 0·029). Similar findings were observed with different cut-off values for a partial MR. A subgroup analysis including only interferon-α2-treated patients showed similar results. In multivariate analyses, the OS was significantly better for never-smokers (HR, 0·46; 95% CI, 0·29-0·75; P = 0·002) than current smokers. The differences were more pronounced in the pegylated interferon-α2-treated patients. However, no significant interaction of interferon-α2 treatment was observed. In conclusion, we found that tobacco smoking reduced the rate of MR and OS in patients with MPNs. Cessation of smoking should be encouraged.
引用
- Sørensen AL, Knudsen TA, Skov V, et al. Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms: A retrospective cohort study. Br J Haematol. 2020. PMID: 33169852. doi:10.1111/bjh.17130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。